January Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- January Therapeutics's estimated annual revenue is currently $310k per year.
- January Therapeutics's estimated revenue per employee is $155,000
Employee Data
- January Therapeutics has 2 Employees.
- January Therapeutics grew their employee count by -60% last year.
January Therapeutics's People
| Name | Title | Email/Phone |
|---|
January Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is January Therapeutics?
January Therapeutics is developing next generation targeted anti-cancer therapies. Building upon the finding that protein-based nano-formulations have led to substantial improvements in the efficacy of known drugs, January is developing unique chemical matter to leverage well established anti-cancer mechanisms of action while adding new cancer targeting properties. Our goal is to create novel drugs with superior efficacy and reduced toxicity in hard-to-treat malignancies with initial application in advanced pancreatic, lung, and ovarian cancers.
keywords:N/A
N/A
Total Funding
2
Number of Employees
$310k
Revenue (est)
-60%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0M | 2 | -50% | $1.3M |
#2 | $0M | 2 | 0% | $2.2M |
#3 | $0.1M | 2 | 0% | N/A |
#4 | $0.3M | 2 | -50% | N/A |
#5 | $0.2M | 2 | -50% | N/A |